WALTHAM, Mass.--(BUSINESS WIRE)--OXiGENE, Inc. (NASDAQ: OXGN) (XSSE: OXGN), a clinical stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that the company will present a corporate overview and update at the Cowen 28th Annual Healthcare Conference on Tuesday, March 18th, at 11:00 a.m. EDT (8:00 a.m. PDT), at the Marriott Copley Plaza Hotel in Boston, MA.
